We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 354

U.S. intervenes in False Claims Act suit against biotech company

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 4 2013

The U.S. government has intervened in part of a False Claims Act (FCA) lawsuit against Agave BioSystems, a biotechnology-based small business with

“Gray-market” bill targets drug shortages and price gouging

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

Representative Elijah Cummings (D-Md.) has introduced a bill (H.R. 5853) designed to reform the process in which “gray market” drug companies buy drugs in short supply and then resell them at drastically marked-up prices

News bytes 10 January 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 10 2013

The U.S. Patent and Trademark Office (USPTO) schedules an Additive Manufacturing Partnership Meeting on January 23, 2013, at its Alexandria, Virginia

Tetragenetics Inc. receives $826 million grant for malaria vaccine

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 18 2013

Tetragenetics Inc. has received an $826-million Phase 2 grant as well as new partnerships with two drug companies, according to a news source. The

Science publisher claims submission of prior art to USPTO involves copyright infringement

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 15 2012

A New Jersey-based publishing company has filed copyright infringement lawsuits in federal courts in two states against law firms that submitted citations to or copies of copyrighted articles from scientific journals to the U.S. Patent and Trademark Office (USPTO) with their clients’ patent applications

Presidential Commission to consider bioethical issues at public meeting

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 4 2010

The U.S. Department of Health and Human Services has announced a November 16-17, 2010, public meeting in Atlanta, Georgia, of the Presidential Commission for the Study of Bioethical Issues

CRS issues report on compounded drugs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The Congressional Research Service (CRS) has issued a report titled "Compounded Drugs" to address the risks and oversight issues raised by the

Blaze Bioscience secures $5 million to advance “Tumor Paint” technology

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 21 2012

Seattle-based Blaze Bioscience has reportedly raised $5 million in Series A financing to advance its “Tumor Paint” technology

FTC reports “pay-for-delay” deal trend continuing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 3 2011

The Federal Trade Commission (FTC) has found that the ongoing trend of drug companies settling claims filed by rival generic manufacturers with “pay-for-delay” deals is proceeding unabated

Dialysis equipment maker sues component part supplier for indemnification

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 17 2011

A company that makes dialysis equipment for use in clinics and by patients in their homes has filed a complaint in federal court against a company that supplied a component part which allegedly contained a defect that led to a recall and caused injuries and at least one death